Lion Point Capital’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $515K | Hold |
55,000
| – | – | 3.5% | 14 |
|
|
2025
Q1 | $676K | Hold |
55,000
| – | – | 4.31% | 11 |
|
|
2024
Q4 | $727K | Buy |
55,000
+8,800
| +19% | +$116K | 3.81% | 11 |
|
|
2024
Q3 | $889K | Sell |
46,200
-18,800
| -29% | -$362K | 1.98% | 11 |
|
|
2024
Q2 | $1.33M | Hold |
65,000
| – | – | 2.43% | 7 |
|
|
2024
Q1 | $1.55M | Buy |
65,000
+30,500
| +88% | +$726K | 0.86% | 9 |
|
|
2023
Q4 | $746K | Hold |
34,500
| – | – | 0.37% | 14 |
|
|
2023
Q3 | $501K | Hold |
34,500
| – | – | 0.22% | 21 |
|
|
2023
Q2 | $722K | Buy |
+34,500
| New | +$722K | 0.33% | 18 |
|